International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Drug Products and Drug Packaging for the Elderly

Author(s): Allen Loyd V Jr

Issue: May/Jun 1997 - Geriatric Care
View All Articles in Issue

Page(s): 150-151

Drug Products and Drug Packaging for the Elderly Page 1

Drug Products and Drug Packaging for the Elderly Page 2

Download in electronic PDF format for $75

Abstract: As the fastest-growing market segment for prescribed medications, seniors merit special consideration. This article discusses common problems for this patient group (dosage forms, packaging/labeling, drug identification and dosing). A list of problems/considerations, adapted from Salom IL, Davis K (Geriatrics 1995;50:37-44), accompanies the article.

Related Keywords: Geriatric

Related Categories: GERIATRICS, PACKAGING

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Drug Products and Drug Packaging for the Elderly Allen Loyd V Jr	May/Jun 1997 Pg. 150-151
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W	May/Jun 2016 Pg. 202-206
Pain Management in the Elderly Peralta Alexander Jr	May/Jun 2004 Pg. 187-191
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
The Role of Compounding Pharmacists During Drug Shortages Ofei Kelvin	Jul/Aug 2022 Pg. 298-301
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S	Mar/Apr 2001 Pg. 101-103
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr	Mar/Apr 2011 Pg. 92
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
Compounding with Biotechnology Products, Part 1: General Considerations Allen Loyd V Jr	Sep/Oct 2022 Pg. 385-395
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Akers Michael J	Nov/Dec 2015 Pg. 491-500
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product Allen Loyd V Jr	Jul/Aug 2004 Pg. 292-293
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Uttaro Elizabeth, Zhao Fang, Schweighardt Anne	Sep/Oct 2021 Pg. 364-371
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr	Jul/Aug 2021 Pg. 311-317
PreScription: Factors Related to Drug Waste and Pharmacy Solutions Allen Loyd V Jr	Jul/Aug 2018 Pg. 268
Return to Top